Axsome Logo.png
Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors
19 juin 2017 07h00 HE | Axsome Therapeutics, Inc.
NEW YORK, June 19, 2017 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous...
Aegis Awarded Patent for Non-invasive Nasal Anti-Seizure Drug Formulations
10 mai 2017 08h30 HE | Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwired - May 10, 2017) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 9,642,913, the fourth patent providing non-invasive metered nasal spray...
AdamasLogo_noTM.jpg
Adamas to Announce First Quarter 2017 Financial Results and Host Conference Call on May 9, 2017
02 mai 2017 16h06 HE | Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., May 02, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the company will report first quarter 2017 financial results on Tuesday, May 9,...
AdamasLogo_noTM.jpg
Adamas Pharmaceuticals Completes Phase 1 Clinical Trial of ADS-4101 for Treatment of Partial Onset Seizures in Patients with Epilepsy
03 janv. 2017 16h52 HE | Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced the completion of a Phase 1 clinical trial of ADS-4101, an investigational drug in...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
MRI Interventions’ ClearPoint® Neuro-Navigation System to be Featured at the Congress of Neurological Surgeons (“CNS”), in a Hands-On Workshop Entitled, “Laser Ablation Surgery Practical Clinic”
21 sept. 2016 09h00 HE | MRI Interventions, Inc.
IRVINE, Calif., Sept. 21, 2016 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System will be utilized at a Practical Clinic entitled...
Precision Medicine M
Precision Medicine Market size worth USD 87.7 billion by 2023, to grow at 10.5% CAGR from 2016 to 2023: Global Market Insights Inc.
28 juil. 2016 10h00 HE | Global Market Insights
Ocean View, Delaware, July 28, 2016 (GLOBE NEWSWIRE) -- Precision Medicine Market size is expected to reach USD 87.79 billion by 2023; as per a new research report by Global Market Insights,...
Axsome Logo.png
Axsome Therapeutics Reports First Quarter 2016 Financial Results
11 mai 2016 16h42 HE | Axsome Therapeutics, Inc.
NEW YORK, May 11, 2016 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous...
Axsome Logo.png
Axsome Therapeutics Initiates Phase 3 Study of AXS-05 for Treatment Resistant Depression
17 mars 2016 07h00 HE | Axsome Therapeutics, Inc.
First Patient Enrolled in the STRIDE-1 Study Second Product Candidate Axsome Has Advanced into a Pivotal Trial NEW YORK, March 17, 2016 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc....
Mazor_Robotics_in_OR_4
Mazor Robotics Technology to be Featured in a Live Surgery Presentation at the Congress of Neurological Surgeons Annual Meeting 2015
24 sept. 2015 08h10 HE | Mazor Robotics
ORLANDO, FLA., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Mazor Robotics Renaissance® Guidance System will be featured in a Live Surgery presentation entitled, "Spine: Robotics-guided MIS TLIF" at the...
22157.jpg
Central Nervous System (CNS) Therapeutics - Global Strategic Business Report 2013-2018
22 nov. 2013 09h00 HE | Research and Markets
Dublin, Nov. 22, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/3wllkk/cns_therapeutics) has announced the addition of the "CNS Therapeutics -...